About
Stan Wang is a biotech founder and regenerative-medicine operator best known as the founder and CEO of Thymmune Therapeutics, a company developing thymic cell therapies for immune restoration. He previously co-founded Cellino Biotech and is described by Locust Walk as its former founding CSO. Public profiles also note his scientific training at Cambridge, Columbia, and Harvard, plus advisory work in biosecurity and life sciences.
Areas of interest
biotechregenerative medicineimmunologythymus biologycell therapystem cellslongevitybiosecurity